Innovative Therapies for Skin Disease: What's On the Horizon?

This Course Is Approved for 1 CE Credit     |     Douglas J. DeBoer, DVM, DACVD and  Peter Eeg, BSc, DVM

The landscape of veterinary medicine is changing, particularly in light of recent developments in the introduction of monoclonal antibody therapy. Monoclonal antibodies, increasingly being used in human medicine, are now being introduced for their role in the treatment of atopic dermatitis in dogs. Drs. DeBoer and Eeg will discuss the role of monoclonal antibodies and how they can be applied in real clinical cases.

Please note:

If you were an attendee at this NAVC Conference and received a general CE certificate, please be sure to check with your state licensing bureau regarding your eligibility to receive online credit for an individual session.

Supported and produced by educational grants from Zoetis  in conjunction with NAVC 2016 as part of  the Zoetis Clinical Dermatology: Lessons Learned and Prospective Therapies Symposium.

Back On Top